Orthofix Med Rg
OFIX
USD
STOCK MARKET:
NMS
Closed
 
...
Large gap with delayed quotes
Last quote
11/04/2025 - 23:20:00
Bid
11/04/2025 - 21:59:59
Bid
Volume
Ask
11/04/2025 - 21:59:59
Ask
Volume
14.87
-1.19 ( -7.41% )
14.87
1,200
14.88
2,000
More information
Analysis by TheScreener
31.10.2025
Evaluation Neutral  
Interest Weak  
Sensibility Middle  
Analysis date: 31.10.2025
Global Evaluation
  Neutral
The stock is classified in the neutral zone since 05.08.2025.
Interest
  Weak
Two stars since 21.10.2025.
Earnings Rev Trend
  -0.10
 
Compared to seven weeks ago, the analysts have not significantly revised their earnings per share estimates (changes between +1% and -1% are considered neutral). But the last significant trend is negative since 24.06.2025 at a price of 10.97.
Evaluation
  Strongly overvalued
 
Based on its growth potential and our own criteria, we believe the share price is currently overvalued.
MT Tech Trend
  Positive
 
The dividend-adjusted forty day technical trend is positive since 05.08.2025.
4wk Rel Perf
  3.20%
 
The four-week dividend-adjusted overperformance versus SP500 is 3.20%.
Sensibility
  Middle
The stock has been on the moderate-sensitivity level since 11.02.2025.
Bear Market Factor
  Middle
On average, the stock is likely to decline with the index.
Bad News Factor
  Low
When the stock's pressure is specific, the market sanction on average is 2.60%.
Mkt Cap in $bn
  0.61
With a market capitalization <$2bn, ORTHOFIX MEDICAL is considered a small-cap stock.
G/PE Ratio
  0.41
A ratio (Forecasted Growth + Estimated Dividend Yield/ Estimated Price Earnings) below 0.6 indicates that investors must pay a substantial premium for the estimated growth potential: >50% premium.
LT P/E
  -11.53
The estimated PE is negative: the financial analysts' earnings estimates forecast a loss.
LT Growth
  4.66%
The annualized growth estimate is for the current year to 2027.
Avg. Nb analysts
  3
Over the last seven weeks, an average of 3 analysts provided earnings per share estimates.
Dividend Yield
  0.00%
The company is not paying a dividend.
Beta
  97
For 1% of index variation, the stock varies on average by 0.97%.
Correlation
  0.49
49.08% of stock movements are explained by index variations.
Value at Risk
  3.42
The value at risk is estimated at USD 3.42. The risk is therefore 22.16%. This value is based on the historical volatility for a medium time period (1 month) with a confidence of 95%.
First Analysis Date
  11.07.2008